# A Trial of 18-22mg/kg/d Ursodeoxycholic in Refractory Primary Biliary Cholangitis

> **NCT03345589** · PHASE4 · UNKNOWN · sponsor: **West China Hospital** · enrollment: 40 (estimated)

## Conditions studied

- Primary Biliary Cholangitis

## Interventions

- **DRUG:** 18-22mg/kg/d Ursodeoxycholic
- **DRUG:** 13-15mg/kg/d Ursodeoxycholic

## Key facts

- **NCT ID:** NCT03345589
- **Lead sponsor:** West China Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-01-30
- **Primary completion:** 2018-12-01
- **Final completion:** 2019-01-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2018-05-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03345589

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03345589, "A Trial of 18-22mg/kg/d Ursodeoxycholic in Refractory Primary Biliary Cholangitis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03345589. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*